The National Cancer Institute (NCI) is offering this grant to establish the Acquired Resistance to Therapy Network (ARTNet). This grant is for researchers to investigate the mechanistic basis of acquired resistance to cancer therapies and disease recurrence. Building on previous efforts, ARTNet will employ team science approaches, integrating basic, pre-clinical, and translational research along the tumor-microenvironment continuum. This initiative aims to inform new strategies that can be better translated to overcome significant challenges in acquired resistance to cancer therapies. The NCI seeks applications focusing on innovative research to improve therapeutic outcomes and prevent disease recurrence.
Opportunity ID: 335131
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-21-052 |
| Funding Opportunity Title: | Acquired Resistance to Therapy Network (ARTNet; U54 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.395 — Cancer Treatment Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Aug 04, 2021 |
| Last Updated Date: | Aug 04, 2021 |
| Original Closing Date for Applications: | Nov 01, 2021 |
| Current Closing Date for Applications: | Nov 01, 2021 |
| Archive Date: | Dec 07, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Independent school districts Public and State controlled institutions of higher education County governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Public housing authorities/Indian housing authorities Private institutions of higher education Special district governments State governments Small businesses City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) is inviting applications to form the Acquired Resistance to Therapy Network (ARTNet). The ARTNet FOA is a reissuance that builds upon the Drug Resistance and Sensitivity Network (DRSN, RFA-CA-17-009) to focus study on the mechanistic basis of acquired resistance to cancer therapies and disease recurrence. Central to the ARTNets structural organization is team science approaches that iteratively bridge basic, pre-clinical, and translational research along the tumor-microenvironment continuum to inform new strategies that can be better translated to overcome significant challenges in acquired resistance to cancer therapies. This FOA will be published in parallel with a companion FOA titled Coordinating and Data Management Center (CDMC) for Acquired Resistance to Therapy Network (ARTNet; U24 Clinical Trial Not Allowed). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-21-052.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
OERWebmaster03@od.nih.gov Email:OERWebmaster03@od.nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster OERWebmaster03@od.nih.gov Email: OERWebmaster03@od.nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269646 | Oct 27, 2021 | Nov 01, 2021 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00268422 | Oct 01, 2021 | Jan 24, 2022 | View |
Package 1
Mandatory forms
335131 RR_SF424_5_0-5.0.pdf
335131 PHS398_CoverPageSupplement_5_0-5.0.pdf
335131 RR_OtherProjectInfo_1_4-1.4.pdf
335131 PerformanceSite_4_0-4.0.pdf
335131 RR_KeyPersonExpanded_4_0-4.0.pdf
335131 PHS398_ResearchPlan_4_0-4.0.pdf
335131 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
335131 PHS_Additional_IndirectCosts_2_0-2.0.pdf
335131 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
335131 RR_SF424_2_0-2.0.pdf
335131 PHS398_CoverPageSupplement_5_0-5.0.pdf
335131 RR_OtherProjectInfo_1_4-1.4.pdf
335131 PerformanceSite_2_0-2.0.pdf
335131 RR_KeyPersonExpanded_2_0-2.0.pdf
335131 PHS398_ResearchPlan_4_0-4.0.pdf
335131 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
335131 PHS_Additional_IndirectCosts-1.0.pdf
335131 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
